Cilostazol 100 mg BID

DRUG2 trials

Sponsors

Kowa Research Institute, Inc., Beijing Tiantan Hospital

Conditions

Aneurysmal Subarachnoid HemorrhageIntermittent Claudication

Phase 2

Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

CompletedNCT00783081

Kowa Research Institute, Inc.Intermittent Claudication

Start: 2008-11-30End: 2010-07-31Updated: 2012-03-22

Phase 3

Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage

Not yet recruitingNCT07249853

Beijing Tiantan HospitalAneurysmal Subarachnoid Hemorrhage

Start: 2025-11-30End: 2027-08-31Target: 316Updated: 2025-11-25

Related Papers

Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication.

2011-05-257 citations